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An in-depth annotation of the newly discovered coronavirus (2019-nCoV) genome has revealed differences
between 2019-nCoV and severe acute respiratory syndrome (SARS) or SARS-like coronaviruses. A system-
atic comparison identified 380 amino acid substitutions between these coronaviruses, which may have
caused functional and pathogenic divergence of 2019-nCoV.A novel coronavirus (CoV) named ‘‘2019
novel coronavirus’’ or ‘‘2019-nCoV’’ by
the World Health Organization (WHO) is
responsible for the recent pneumonia
outbreak that started in early December,
2019 in Wuhan City, Hubei Province,
China (Huang et al., 2020; Zhou et al.,
2020; Zhu et al., 2020). This outbreak is
associated with a large seafood and
animal market, and investigations are
ongoing to determine the origins of the
infection. To date, thousands of human in-
fections have been confirmed in China
along with many exported cases across
the globe (China CDC, 2020).
Coronavirusesmainly cause respiratory
and gastrointestinal tract infections and
are genetically classified into four major
genera: Alphacoronavirus, Betacoronavi-
rus, Gammacoronavirus, and Deltacoro-
navirus (Li, 2016). The former two genera
primarily infect mammals, whereas the
latter two predominantly infect birds
(Tang et al., 2015). Six kinds of human
CoVs have been previously identified.
These include HCoV-NL63 and HCoV-
229E, which belong to the Alphacoro-
navirus genus; and HCoV-OC43, HCoV-
HKU1, severe acute respiratory syndrome
coronavirus (SARS-CoV), and Middle
East respiratory syndrome coronavirus
(MERS-CoV), which belong to the Beta-coronavirus genus (Tang et al., 2015). Co-
ronaviruses did not attract worldwide
attention until the 2003 SARS pandemic,
followed by the 2012 MERS and, most
recently, the 2019-nCoV outbreaks (China
CDC, 2020; Song et al., 2019). SARS-CoV
and MERS-CoV are considered highly
pathogenic (Cui et al., 2019), and it is
very likely that both SARS-CoV and
MERS-CoV were transmitted from bats
to palm civets (Guan et al., 2003) or drom-
edary camels (Drosten et al., 2014), and
finally to humans (Cui et al., 2019).
The genome of coronaviruses, whose
size ranges between approximately
26,000 and 32,000 bases, includes a var-
iable number (from 6 to 11) of open
reading frames (ORFs) (Song et al.,
2019). The first ORF representing approx-
imately 67% of the entire genome en-
codes 16 non-structural proteins (nsps),
while the remaining ORFs encode acces-
sory proteins and structural proteins (Cui
et al., 2019). The four major structural pro-
teins are the spike surface glycoprotein
(S), small envelope protein (E), matrix pro-
tein (M), and nucleocapsid protein (N).
The spike surface glycoprotein plays an
essential role in binding to receptors on
the host cell and determines host tropism
(Li, 2016; Zhu et al., 2018). The spike pro-
teins of SARS-CoV and MERS-CoV bindCell Host & Microbe 2to different host receptors via different re-
ceptor-binding domains (RBDs). SARS-
CoV uses angiotensin-converting enzyme
2 (ACE2) as one of the main receptors (Ge
et al., 2013) with CD209L as an alternative
receptor (Jeffers et al., 2004), whereas
MERS-CoV uses dipeptidyl peptidase 4
(DPP4, also known as CD26) as the
primary receptor. Initial analysis sug-
gested that 2019-nCoV has a close
evolutionary association with the SARS-
like bat coronaviruses (Zhou et al.,
2020). Here, based on the first three
determined genomes of the novel coro-
navirus (2019-nCoV), namely Wuhan/
IVDC-HB-01/2019 (GISAID accession ID:
EPI_ISL_402119) (HB01), Wuhan/IVDC-
HB-04/2019 (EPI_ISL_402120) (HB04),
and Wuhan/IVDC-HB-05/2019 (EPI_
ISL_402121) (HB05), an in-depth genome
annotation of this virus was performed
with a comparison to related coronavi-
ruses, including 1,008 human SARS-
CoV, 338 bat SARS-like CoV, and 3,131
human MERS-CoV, whose genomes
were published before January 12, 2020
(release date: September 12, 2019) from
Virus Pathogen Database and Analysis
Resource (ViPR) (http://www.viprbrc.
org/) and NCBI.
Comparison of genomes of these three
strains showed that they are almost7, March 11, 2020 ª 2020 Elsevier Inc. 325
pp1a S
3a E M 7a
7b
N
5’UTR 3’UTR
1
181 819 2764 3264 3570
4141
4254
nsp1 nsp2 nsp3 nsp4 nsp5 nsp6 nsp8 nsp9 nsp10
IVDC-HB-01/2019  (~29.8kb)
3b p6
8b
9b orf14
pp1ab
3860
3943
nsp7 4392
4393
53255926
nsp12nsp13nsp14nsp15nsp16
64536799
7096
MERS-CoV
Human
SARS-CoV
SARS-like 
bat CoV
2019-nCoV
MERS-CoVHB-01/2019
SARS-like bat CoV Human SARS-CoV
Other CoVsAlphacoronavirusBetacoronavirus
Gammacoronavirus
Deltacoronavirus
whole genome pp1a pp1ab spike
3a envelope matrix
7a 8b nucleocapsid
A
B C
Figure 1. Genome composition and phylogenetic tree for 2019-nCoV
(A) Schematic diagram of the genome organization and the encoded proteins of pp1ab and pp1a for the IVDC-HB-01/2019 (HB01) strain. The largest gene,
namely the orf1ab, encodes the pp1ab protein that contains 15 nsps (nsp1-nsp10 and nsp12-nsp16). The pp1a protein encoded by the orf1a gene also contains
10 nsps (nsp1-nsp10). Structural proteins are encoded by the four structural genes, including spike (S), envelope (E), membrane (M), and nucleocapsid (N) genes.
The accessory genes are distributed among the structural genes. The protein-encoding genes of the genome of 2019-nCoV were predicted by the online servers
of GeneMarkS (http://exon.gatech.edu/GeneMark/genemarks.cgi) and ORFfinder (https://www.ncbi.nlm.nih.gov/orffinder/) with manual check.
(B) Phylogenetic relationship based on the whole genome for the HB01 strain and other coronaviruses. All viral strains were classified by the genus and the type,
which are presented on the left and right schematic phylogenetic trees, respectively. The four genera of the coronaviruses, including Alphacoronavirus (red),
Betacoronavirus (blue), Gammacoronavirus (green), and Deltacoronavirus (violet) are blocked in the left phylogenetic tree. The MERS coronavirus (brown), the
SARS-like bat coronavirus (violet), human SARS coronavirus (light blue), and the HB01 strain (red) are highlighted by lines of different colors in the right
phylogenetic tree.
(C) Schematic phylogenetic trees of individual genes for the HB01 strain. The coronavirus species were colored in the same way as (B). The amount of the strains
in the phylogenetic clade is denoted by the area of the circles.
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Commentaryidentical, with only five nucleotide differ-
ences in the genome of ~29.8 kb nucleo-
tides (Figure S1). The 2019-nCoV genome
was annotated to possess 14 ORFs en-
coding 27 proteins (Figure 1A and Tables
S1A and S1B). The orf1ab and orf1a
genes located at the 50-terminus of the
genome respectively encode the pp1ab
and pp1a proteins, respectively. They
together comprise 15 nsps including
nsp1 to nsp10 and nsp12 to nsp16
(Figure 1A and Table S1B). The 30-termi-
nus of the genome contains four structural
proteins (S, E, M, and N) and eight acces-
sory proteins (3a, 3b, p6, 7a, 7b, 8b, 9b,
and orf14). At the amino acid level, the326 Cell Host & Microbe 27, March 11, 20202019-nCoV is quite similar to that of
SARS-CoV, but there are some notable
differences. For example, the 8a protein
is present in SARS-CoV and absent in
2019-nCoV; the 8b protein is 84 amino
acids in SARS-CoV, but longer in 2019-
nCoV, with 121 amino acids; the 3b pro-
tein is 154 amino acids in SARS-CoV,
but shorter in 2019-nCoV, with only 22
amino acids (Table S1A). Further studies
are needed to characterize how these dif-
ferences affect the functionality and path-
ogenesis of 2019-nCoV.
As shown in a phylogenetic tree based
on whole genomes (Figures 1B and S2)
with the Molecular Evolutionary GeneticsAnalysis (MEGA) (version 7.0), the 2019-
nCoV is in the same Betacoronavirus
clade as MERS-CoV, SARS-like bat
CoV, and SARS-CoV. The phylogenetic
tree falls into two clades. TheBetacorona-
virus genus constitutes one clade, while
the Alphacoronavirus, Gammacoronavi-
rus, and Deltacoronavirus genera consti-
tute the other clade. The 2019-nCoV is
parallel to the SARS-like bat CoVs, while
the SARS-CoVs are descended from the
SARS-like bat CoVs, indicating that
2019-nCoV is closer to the SARS-like
bat CoVs than the SARS-CoVs in terms
of the whole genome sequence. Tables
S1C and S1D also show that the genome
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Figure 2. Amino Acid Substitutions of 2019-nCoV against SARS and SARS-like Viruses
All 27 proteins encoded by 2019-nCoV have been aligned against SARS-CoVs and SARS-like bat CoVs using the FFT-NS-2 algorithm in MAFFT (version v7.407)
(The number of aligned proteins were listed in Table S1E). An amino acid substitution was defined as an absolutely conserved site in the group of SARS and
SARS-like CoVs but different from that of 2019-nCoV. In total, 380 amino acid substitutions have been identified between the amino acid sequences of 2019-
nCoV (HB01) and the corresponding consensus sequences of SARS and SARS-like CoVs.
Cell Host & Microbe
Commentaryof 2019-nCoV has the highest similarity
with that of a SARS-like bat CoV
(MG772933). In comparison, 2019-nCoV
is distant from and less related to the
MERS-CoVs. In terms of the encoded
proteins of pp1ab, pp1a, envelope, ma-trix, accessory protein 7a, and nucleo-
capsid genes, phylogenetic analyses
showed that the 2019-nCoV is closest to
the SARS-like bat CoVs (Figure 1C and
Table S1D). Regarding the spike gene,
the 2019-nCoV is closest to the batCCoVs, while the 3a and 8b accessory
genes are both closest to the SARS-
CoVs. Although phylogenetic analyses
for the whole genome and individual
genes clearly show that the 2019-nCoV
is most closely related to SARS-like batell Host & Microbe 27, March 11, 2020 327
Cell Host & Microbe
Commentaryviruses (Figures 1B and 1C), we did not
find a single strain of a SARS-like bat virus
that harbors all proteins with the most
similarity to counterparts of the 2019-
nCoV (Figures 1B and 1C).
Given the close relationship between
2019-nCoV and SARS-CoVs or SARS-
like bat CoVs (Figures 1B and 1C), an ex-
amination of the amino acid substitutions
in different proteins could shed light into
how 2019-nCoV differs structurally and
functionally from SARS-CoVs. In total,
there were 380 amino acid substitutions
between the amino acid sequences of
2019-nCoV (HB01) and the correspond-
ing consensus sequences of SARS and
SARS-like viruses (Figure 2 and Tables
S1E and S1F). No amino acid substitu-
tions occurred in nonstructural protein 7
(nsp7), nsp13, envelope, matrix, or acces-
sory proteins p6 and 8b (Table S1F).
Respectively, 102 and 61 amino acid sub-
stitutions are located in nsp3 and nsp2. In
addition, 27 amino acid substitutions
were found in the spike protein with a
length of 1,273 amino acids, including
six substitutions in the RBD at amino
acid region 357-528 and six substitutions
in the underpinning subdomain (SD)
at amino acid region 569-655. More-
over, four substitutions (Q560L, S570A,
F572T, and S575A) in the C-terminal of
the receptor-binding subunit S1 domain
(Figure 2) are situated in two peptides pre-
viously reported to be antigens for SARS-
CoV (Guo et al., 2004).
Due to very limited knowledge of this
novel virus, we are unable to give reason-
able explanations for the significant num-
ber of amino acid substitutions between
the 2019-nCoV and SARS or SARS-like
CoVs. For example, no amino acid substi-
tutions were present in the receptor-bind-328 Cell Host & Microbe 27, March 11, 2020ing motifs that directly interact with
human receptor ACE2 protein in SAR-
S-CoV (Ge et al., 2013), but six mu-
tations occurred in the other region of
the RBD. Whether these differences
could affect the host tropism and
transmission property of the 2019-nCoV
compared to SARS-CoV is worthy of
future investigation.
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